Proteases
Proteases, also known as peptidases or proteolytic enzymes, consists of a large number of enzymes catalyzing the hydrolysis of peptide bonds and subsequently resulting in the degradation of protein substrates into amino acids. Proteases are involved in a wide range of human diseases, including cancer, neurodegenerative disorders, inflammatory diseases and cardiovascular diseases. Thus numerous proteases inhibitors (small molecules and proteins) have been identified to block activity of proteases. Proteases inhibitors can be classified into different types based on the class of proteases they inhibit through two general mechanisms, irreversible “trapping” reactions and reversible tight-binding reactions. Proteases inhibitors have been used as diagnostic or therapeutic agents for the treatment of proteases-related diseases.
- C3492 RamiprilatSummary: angiotensin-converting enzyme inhibitor
- C3609 (Z-Ala-Ala-Ala-Ala)2Rh110Summary: fluorogenic elastase substrate
- C3622 TNP-470Summary: methionine aminopeptidase-2 (MetAP2) inhibitor
- C3931 ResorcinolnaphthaleinSummary: ACE2 activator
- C3966 Sitagliptin (phosphate)Summary: DPP-4 inhibitor
- C3708 L-Leucine 4-methoxy-β-naphthylamide (hydrochloride)Summary: substrate for aminopeptidase M and leucine aminopeptidase
- C4021 TS 155-2Summary: macrocyclic lactone that inhibits thrombin-stimulated calcium entry into cells
- C4189 Arphamenine B (hemisulfate)Summary: aminopeptidase B inhibitor
- C4081 MMP Inhibitor IISummary: MMPs inhibitor
- C4331 MMP-13 InhibitorSummary: MMP-13 inhibitor